Your browser doesn't support javascript.
loading
SGLT2 inhibitors improve plasma atherogenic biomarkers in patients with type 2 diabetes: a real-world retrospective observational study.
Imre, Eren; Gunhan, Hatice G; Erel, Pinar; Ustay, Ozlem.
Afiliação
  • Imre E; Department of Endocrinology and Metabolism, Dr Ersin Arslan Training and Research Hospital, Gaziantep, Türkiye.
  • Gunhan HG; Department of Internal Medicine, Marmara University Training and Research Hospital, Istanbul, Türkiye.
  • Erel P; Department of Internal Medicine, Suhut State Hospital, Afyon, Türkiye.
  • Ustay O; School of Medicine, Department of Endocrinology and Metabolism, Marmara University, Istanbul, Türkiye - drozlemustay@gmail.com.
Minerva Endocrinol (Torino) ; 48(3): 295-304, 2023 Sep.
Article em En | MEDLINE | ID: mdl-33979071
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Aterosclerose / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Aterosclerose / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article